A. Miller

发表

Personalized Medicine and Theranostics

E. Staun-ram, N. Avidan, I. Lejbkowicz, 2016 .

T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles

S. Tong, E. B. Clemens, K. Kedzierska, 2022, Frontiers in Immunology.

CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph

S. Tangye, F. Luciani, C. Szeto, 2020, Nature Communications.

HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis

E. Staun-ram, A. Miller, D. Golan, 2019, Multiple sclerosis journal - experimental, translational and clinical.

Influenza virus vaccination of patients with multiple sclerosis

Aaron E. Miller, F. Mokhtarian, D. Grob, 1997, Multiple sclerosis.

Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.

F. Mokhtarian, D. Grob, A. Miller, 1994, Journal of immunology.

Presence of cross-reactive antibodies to HTLV-1 and absence of antigens in patients with multiple sclerosis.

F. Mokhtarian, D. Grob, A. Miller, 1993, The Journal of laboratory and clinical medicine.

Genomic profiling of interpopulation diversity guides prioritization of candidate-genes for autoimmunity

J. Beckmann, D. Lancet, Ariel Miller, 2004, Genes and Immunity.

Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel

J. Oksenberg, J. Wang, N. Avidan, 2010, Genes and Immunity.

HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people

C. Szeto, L. Loh, S. Tong, 2022, PLoS pathogens.

Comparative therapeutic potential of ALX-0171 and palivizumab against RSV clinical isolate infection of well-differentiated primary pediatric bronchial epithelial cell cultures

M. Shields, U. Power, L. Detalle, 2019, bioRxiv.

Characterization of in vivo-activated T cell clones from peripheral blood of multiple sclerosis patients.

F. Mokhtarian, D. Grob, A. Miller, 1991, Clinical immunology and immunopathology.

Challenging immunodominance of influenza-specific CD8+ T cell responses restricted by the risk-associated HLA-A*68:01 allomorph

S. Tong, E. B. Clemens, Thi H. O. Nguyen, 2019, Nature Communications.

Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities

M. Davenport, K. Subbarao, J. Crawford, 2023, Nature Immunology.

Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19.

E. B. Clemens, Thi H. O. Nguyen, K. Kedzierska, 2023, Immunology and cell biology.